Works in Neuro-Oncology, 2024, Vol 26, Issue 3


Results: 23
    1

    Forthcoming Meetings.

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 3, p. 592, doi. 10.1093/neuonc/noae010
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8

    Associations between recurrence patterns and outcome in glioblastoma patients undergoing re-resection: A complementary report of the RANO resect group.

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 3, p. 584, doi. 10.1093/neuonc/noad237
    By:
    • Karschnia, Philipp;
    • Dono, Antonio;
    • Young, Jacob S;
    • Juenger, Stephanie T;
    • Teske, Nico;
    • Häni, Levin;
    • Sciortino, Tommaso;
    • Mau, Christine Y;
    • Bruno, Francesco;
    • Nunez, Luis;
    • Morshed, Ramin A;
    • Haddad, Alexander F;
    • Weller, Michael;
    • van den Bent, Martin;
    • Thon, Niklas;
    • Beck, Juergen;
    • Hervey-Jumper, Shawn;
    • Molinaro, Annette M;
    • Tandon, Nitin;
    • Rudà, Roberta
    Publication type:
    Article
    9
    10
    11
    12

    Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group.

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 3, p. 407, doi. 10.1093/neuonc/noad227
    By:
    • Mueller, Sabine;
    • Fangusaro, Jason;
    • Thomas, Arzu Onar;
    • Jacques, Thomas S;
    • Bandopadhayay, Pratiti;
    • Blank, Peter de;
    • Packer, Roger J;
    • Fouladi, Maryam;
    • Meeteren, Antoinette Schouten van;
    • Jones, David;
    • Perry, Arie;
    • Nakano, Yoshiko;
    • Hargrave, Darren;
    • Riedl, David;
    • Robison, Nathan J;
    • Partanen, Marita;
    • Fisher, Michael J;
    • Witt, Olaf
    Publication type:
    Article
    13
    14
    15

    Proteometabolomics of initial and recurrent glioblastoma highlights an increased immune cell signature with altered lipid metabolism.

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 3, p. 488, doi. 10.1093/neuonc/noad208
    By:
    • Cosenza-Contreras, Miguel;
    • Schäfer, Agnes;
    • Sing, Justin;
    • Cook, Lena;
    • Stillger, Maren N;
    • Chen, Chia-Yi;
    • Hidalgo, Jose Villacorta;
    • Pinter, Niko;
    • Meyer, Larissa;
    • Werner, Tilman;
    • Bug, Darleen;
    • Haberl, Zeno;
    • Kübeck, Oliver;
    • Zhao, Kai;
    • Stei, Susanne;
    • Gafencu, Anca Violeta;
    • Ionita, Radu;
    • Brehar, Felix M;
    • Ferrer-Lozano, Jaime;
    • Ribas, Gloria
    Publication type:
    Article
    16
    17
    18
    19
    20
    21

    Mean global DNA methylation serves as independent prognostic marker in IDH-wildtype glioblastoma.

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 3, p. 503, doi. 10.1093/neuonc/noad197
    By:
    • Eckhardt, Alicia;
    • Drexler, Richard;
    • Schoof, Melanie;
    • Struve, Nina;
    • Capper, David;
    • Jelgersma, Claudius;
    • Onken, Julia;
    • Harter, Patrick N;
    • Weber, Katharina J;
    • Divé, Iris;
    • Rothkamm, Kai;
    • Hoffer, Konstantin;
    • Klumpp, Lukas;
    • Ganser, Katrin;
    • Petersen, Cordula;
    • Ricklefs, Franz;
    • Kriegs, Malte;
    • Schüller, Ulrich
    Publication type:
    Article
    22
    23

    Diffuse midline glioma invasion and metastasis rely on cell-autonomous signaling.

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 3, p. 553, doi. 10.1093/neuonc/noad161
    By:
    • Bruschi, Marco;
    • Midjek, Lilia;
    • Ajlil, Yassine;
    • Vairy, Stephanie;
    • Lancien, Manon;
    • Ghermaoui, Samia;
    • Kergrohen, Thomas;
    • Verreault, Maite;
    • Idbaih, Ahmed;
    • Biagi, Carlos Alberto Oliveira de;
    • Liu, Ilon;
    • Filbin, Mariella G;
    • Beccaria, Kevin;
    • Blauwblomme, Thomas;
    • Puget, Stephanie;
    • Tauziede-Espariat, Arnault;
    • Varlet, Pascale;
    • Dangouloff-Ros, Volodia;
    • Boddaert, Nathalie;
    • Teuff, Gwenael Le
    Publication type:
    Article